FRA/NOV (FRA/NOV)

Frankfurt Stock Exchange: FRA/NOV · EUR

€34.9

+0.36 (+1.0%)· Recorded snapshot

Market cap	153.6B
Revenue (ttm)	44.1B
Net income (ttm)	15.6B
EPS (ttm)	€3.50
P/E (trailing)	10.0x
P/E (forward)	11.7x
Dividend	€1.57 (4.49%)
Volume	1,785

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 44.1B
Net income (ttm): 15.6B
EPS (ttm): €3.50
P/E (trailing): 10.0x
P/E (forward): 11.7x
Market cap: 153.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.7

P25 n/aP50 n/aP75 n/a

Trailing P/E10

P25 n/aP50 n/aP75 n/a

ROE59.8

P25 n/aP50 n/aP75 n/a

ROIC39.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All FRA/NOV indicators

Market & fundamental data

Available fields

259

Groups with data

Currency

DKK

Showing 259 of 259 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Denmark
Country code	DE
Earnings date	2026-11-04
Employees	66,700
Employees change	-7,844
Employees growth	-10.14%
Enterprise value	EUR 166.3B
Exchange	Frankfurt Stock Exchange
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1923
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	DK0062498333
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2023-09-13
Last stock split type	Forward
Market cap	EUR 153.6B
Next earnings date	2026-11-04
Price	EUR 34.90
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	fra/NOV
Website	https://www.novonordisk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.52x
Average P/E ratio (3Y)	26.67x
Average P/E ratio (5Y)	30.16x
Earnings yield	10.04%
EV/Earnings	10.68x
EV/EBIT	7.7x
EV/EBITDA	7.09x
EV/FCF	16.39x
EV/Sales	3.77x
FCF / EV yield	6.1%
FCF yield	6.61%
Forward P/E	11.69x
Graham number	23.14506
Graham upside	-33.68%
Lynch fair value	EUR 75.35
Lynch upside	115.91%
P/(FCF - SBC) ratio	15.43x
P/(OCF - SBC) ratio	8.8x
P/B ratio	5.19x
P/E ratio	9.96x
P/FCF ratio	15.14x
P/OCF ratio	8.71x
P/S ratio	3.49x
Price / tangible book value	11.57x
Price/EBITDA ratio	6.61x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	48.99%
EBITDA margin	52.72%
Effective tax rate	21.72%
FCF margin	23.02%
Gross margin	81.99%
Operating margin	48.99%
Pretax margin	45.15%
Profit margin	35.35%
Profit per employee	EUR 233,507
Profitable quarters	164
Profitable years	41
Revenue per employee	EUR 660,619
ROA	18.73%
ROA (5Y)	21.35%
ROCE	45.35%
ROE	59.82%
ROE (5Y)	74.56%
ROIC	39.22%
ROIC (5Y)	68.16%
SBC / revenue	0.44%
Tax / revenue	9.81%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	4.98%
EPS growth (Q)	-20.61%
EPS growth (QoQ)	-56.63%
EPS growth 10Y	14.01%
EPS growth 3Y	20.74%
EPS growth 5Y	22.33%
EPS growth years	31
FCF growth	14.3%
FCF growth (Q)	56.84%
FCF growth (QoQ)	232.92%
FCF growth 3Y	2.24%
FCF growth 5Y	9.51%
Gross profit growth	2.76%
Gross profit growth (Q)	-4.1%
Gross profit growth 3Y	16.73%
Gross profit growth 5Y	20.17%
Net income growth	4.84%
Net income growth (Q)	-20.81%
Net income growth (QoQ)	-56.77%
Net income growth 3Y	20.09%
Net income growth 5Y	21.29%
Net income growth years	38
OCF growth	7.52%
OCF growth (Q)	32.14%
OCF growth (QoQ)	129.19%
OCF growth 10Y	11.56%
OCF growth 3Y	13.7%
OCF growth 5Y	19.47%
Operating income growth	9.29%
Operating income growth (Q)	-0.18%
Operating income growth 3Y	22.91%
Operating income growth 5Y	24.43%
Revenue growth	5.61%
Revenue growth (Q)	2.12%
Revenue growth (QoQ)	-18.94%
Revenue growth 10Y	11.56%
Revenue growth 3Y	17.84%
Revenue growth 5Y	20.45%
Revenue growth quarters	2
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -7.5B
Depreciation and amortization	EUR 1.6B
EBIT	EUR 21.6B
EBITDA	EUR 23.2B
EPS	EUR 3.50
Financing cash flow	EUR -3B
Free cash flow	EUR 10.1B
Free cash flow minus SBC	EUR 10B
Gross profit	EUR 36.1B
Income taxes	EUR 4.3B
Investing cash flow	EUR -11.2B
Net borrowing	EUR 4.9B
Net cash flow	EUR 3.5B
Net income	EUR 15.6B
Operating cash flow minus SBC	EUR 17.4B
Operating income	EUR 21.6B
Revenue	EUR 44.1B
Stock-based compensation	EUR 191.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.21
Book value per share	EUR 6.68
Debt / EBITDA	0.8
Debt / equity	0.63
Debt / FCF	1.85
Goodwill	EUR 2.7B
Interest coverage	1,566.84
Long-term assets	EUR 51.7B
Long-term liabilities	EUR 18B
Net cash (debt)	EUR -12.7B
Net cash / market cap	-8.29%
Net debt / EBITDA	0.55
Net debt / equity	0.43
Net debt / FCF	1.25
Piotroski F-Score	5
Property, plant and equipment	EUR 31B
Shareholders' equity	EUR 29.6B
Tangible book value	EUR 13.3B
Tangible book value per share	EUR 3.00
Total assets	EUR 79.6B
Total cash	EUR 6B
Total debt	EUR 18.7B
Total liabilities	EUR 50B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.61
Current assets	EUR 27.9B
Current liabilities	EUR 32B
Current ratio	0.87
Inventory turnover	1.22
Net working capital	EUR -7.6B
Quick ratio	0.64
Working capital	EUR -4.1B
Working capital turnover	-1.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.14%
Dividend growth	0.26%
Dividend growth (10Y)	9.51%
Dividend growth (3Y)	18.14%
Dividend growth (5Y)	20.02%
Dividend growth years	8
Dividend payment date	2026-08-18
Dividend payment years	27
Dividend payout frequency	Semi-Annual
Dividend per share	EUR 1.57
Dividend yield	4.49%
Ex-dividend date	2026-08-14
Last dividend	EUR 0.50
Payout ratio	44.64%
Shareholder yield	4.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	89.21%
10Y return CAGR	9.12%
10Y total return	139.23%
150-day SMA	EUR 38.00
15Y price change	379%
15Y return CAGR	13.49%
15Y total return	566.99%
1D price change	1.04%
1M price change	2.36%
1M total return	2.36%
1W price change	1.99%
1W total return	1.99%
1Y price change	-24.2%
1Y return CAGR	-20.58%
1Y total return	-20.56%
20-day SMA	EUR 34.25
200-day SMA	EUR 38.38
20Y price change	1,048.03%
20Y return CAGR	15.89%
20Y total return	1,807.93%
3M price change	-19.22%
3M total return	-18.2%
3Y price change	-61.75%
3Y return CAGR	-25.3%
3Y total return	-58.32%
50-day SMA	EUR 36.46
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 54.86
52-week high date	2026-01-23
52-week low	EUR 30.29
52-week low date	2026-03-27
5Y price change	-24.2%
5Y return CAGR	-3.22%
5Y total return	-15.1%
6M price change	-0.43%
6M total return	0.83%
All-time high	EUR 140.00
All-time high date	2024-06-26
All-time low	EUR 1.13
All-time low date	2002-07-26
Average true range (ATR)	EUR 0.87
Average volume	14.5K
Change from 52-week high	-36.38%
Change from 52-week low	15.22%
Change from all-time high	-75.07%
Change from all-time low	3,002.22%
Change from open	-0.57%
Day's gap	1.62%
Dollar volume	EUR 62,297
High price	EUR 35.10
Low price	EUR 34.51
Monthly RSI	35.6
Open price	EUR 35.10
Position in 52-week range	66.1%
Previous close	EUR 34.54
Price vs 150-day SMA	-8.15%
Price vs 20-day SMA	1.89%
Price vs 200-day SMA	-9.06%
Price vs 50-day SMA	-4.27%
Relative volume	0.12
RSI	48.69
Sharpe ratio	-0.32
Sharpe ratio (3Y)	-0.56
Sharpe ratio (5Y)	-0.03
Sortino ratio	-0.31
Sortino ratio (3Y)	-0.61
Sortino ratio (5Y)	0.1
Volume	1.8K
Weekly RSI	40.17
YTD price change	-20.76%
YTD total return	-16.96%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.2B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.14%
Shares held by insiders	0.02%
Shares held by institutions	27.53%

Deeper analysis on FRA/NOV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this FRA/NOV report

Is a complete FRA/NOV research report available?

No complete published report is available for fra/NOV (FRA/NOV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

153.6B

Revenue (ttm)

44.1B

Net income (ttm)

15.6B

EPS (ttm)

€3.50

P/E (trailing)

10.0x

P/E (forward)

11.7x

Dividend

€1.57 (4.49%)

Volume

1,785

Metric

Value

Amount currency

EUR

Country

Denmark

Country code

Earnings date

2026-11-04

Employees

66,700

Employees change

-7,844

Employees growth

-10.14%

Enterprise value

EUR 166.3B

Exchange

Frankfurt Stock Exchange

Financial currency

DKK

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1923

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

DK0062498333

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split date

2023-09-13

Last stock split type

Forward

Market cap

EUR 153.6B

Next earnings date

2026-11-04

Price

EUR 34.90

Price currency

EUR

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-27

Symbol

fra/NOV

Website

https://www.novonordisk.com

Metric

Value

Average P/E ratio (10Y)

25.52x

Average P/E ratio (3Y)

26.67x

Average P/E ratio (5Y)

30.16x

Earnings yield

10.04%

EV/Earnings

10.68x

EV/EBIT

7.7x

EV/EBITDA

7.09x

EV/FCF

16.39x

EV/Sales

3.77x

FCF / EV yield

6.1%

FCF yield

6.61%

Forward P/E

11.69x

Graham number

23.14506

Graham upside

-33.68%

Lynch fair value

EUR 75.35

Lynch upside

115.91%

P/(FCF - SBC) ratio

15.43x

P/(OCF - SBC) ratio

8.8x

P/B ratio

5.19x

P/E ratio

9.96x

P/FCF ratio

15.14x

P/OCF ratio

8.71x

P/S ratio

3.49x

Price / tangible book value

11.57x

Price/EBITDA ratio

6.61x

Sector forward P/E

14.8x

Sector P/E

39.91x

Metric

Value

EBIT margin

48.99%

EBITDA margin

52.72%

Effective tax rate

21.72%

FCF margin

23.02%

Gross margin

81.99%

Operating margin

48.99%

Pretax margin

45.15%

Profit margin

35.35%

Profit per employee

EUR 233,507

Profitable quarters

164

Profitable years

Revenue per employee

EUR 660,619

ROA

18.73%

ROA (5Y)

21.35%

ROCE

45.35%

ROE

59.82%

ROE (5Y)

74.56%

ROIC

39.22%

ROIC (5Y)

68.16%

SBC / revenue

0.44%

Tax / revenue

9.81%

Metric

Value

EPS growth

4.98%

EPS growth (Q)

-20.61%

EPS growth (QoQ)

-56.63%

EPS growth 10Y

14.01%

EPS growth 3Y

20.74%

EPS growth 5Y

22.33%

EPS growth years

FCF growth

14.3%

FCF growth (Q)

56.84%

FCF growth (QoQ)

232.92%

FCF growth 3Y

2.24%

FCF growth 5Y

9.51%

Gross profit growth

2.76%

Gross profit growth (Q)

-4.1%

Gross profit growth 3Y

16.73%

Gross profit growth 5Y

20.17%

Net income growth

4.84%

Net income growth (Q)

-20.81%

Net income growth (QoQ)

-56.77%

Net income growth 3Y

20.09%

Net income growth 5Y

21.29%

Net income growth years

OCF growth

7.52%

OCF growth (Q)

32.14%

OCF growth (QoQ)

129.19%

OCF growth 10Y

11.56%

OCF growth 3Y

13.7%

OCF growth 5Y

19.47%

Operating income growth

9.29%

Operating income growth (Q)

-0.18%

Operating income growth 3Y

22.91%

Operating income growth 5Y

24.43%

Revenue growth

5.61%

Revenue growth (Q)

2.12%

Revenue growth (QoQ)

-18.94%

Revenue growth 10Y

11.56%

Revenue growth 3Y

17.84%

Revenue growth 5Y

20.45%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

EUR -7.5B

Depreciation and amortization

EUR 1.6B

EBIT

EUR 21.6B

EBITDA

EUR 23.2B

EPS

EUR 3.50

Financing cash flow

EUR -3B

Free cash flow

EUR 10.1B

Free cash flow minus SBC

EUR 10B

Gross profit

EUR 36.1B

Income taxes

EUR 4.3B

Investing cash flow

EUR -11.2B

Net borrowing

EUR 4.9B

Net cash flow

EUR 3.5B

Net income

EUR 15.6B

Operating cash flow minus SBC

EUR 17.4B

Operating income

EUR 21.6B

Revenue

EUR 44.1B

Stock-based compensation

EUR 191.9M

Metric

Value

Altman Z-Score

4.21

Book value per share

EUR 6.68

Debt / EBITDA

0.8

Debt / equity

0.63

Debt / FCF

1.85

Goodwill

EUR 2.7B

Interest coverage

1,566.84

Long-term assets

EUR 51.7B

Long-term liabilities

EUR 18B

Net cash (debt)

EUR -12.7B

Net cash / market cap

-8.29%

Net debt / EBITDA

0.55

Net debt / equity

0.43

Net debt / FCF

1.25

Piotroski F-Score

Property, plant and equipment

EUR 31B

Shareholders' equity

EUR 29.6B

Tangible book value

EUR 13.3B

Tangible book value per share

EUR 3.00

Total assets

EUR 79.6B

Total cash

EUR 6B

Total debt

EUR 18.7B

Total liabilities

EUR 50B

Metric

Value

Asset turnover

0.61

Current assets

EUR 27.9B

Current liabilities

EUR 32B

Current ratio

0.87

Inventory turnover

1.22

Net working capital

EUR -7.6B

Quick ratio

0.64

Working capital

EUR -4.1B

Working capital turnover

-1.17

Metric

Value

Buyback yield / dilution

0.14%

Dividend growth

0.26%

Dividend growth (10Y)

9.51%

Dividend growth (3Y)

18.14%

Dividend growth (5Y)

20.02%

Dividend growth years

Dividend payment date

2026-08-18

Dividend payment years

Dividend payout frequency

Semi-Annual

Dividend per share

EUR 1.57

Dividend yield

4.49%

Ex-dividend date

2026-08-14

Last dividend

EUR 0.50

Payout ratio

44.64%

Shareholder yield

4.63%

Metric

Value

10Y price change

89.21%

10Y return CAGR

9.12%

10Y total return

139.23%

150-day SMA

EUR 38.00

15Y price change

379%

15Y return CAGR

13.49%

15Y total return

566.99%

1D price change

1.04%

1M price change

2.36%

1M total return

2.36%

1W price change

1.99%

1W total return

1.99%

1Y price change

-24.2%

1Y return CAGR

-20.58%

1Y total return

-20.56%

20-day SMA

EUR 34.25

200-day SMA

EUR 38.38

20Y price change

1,048.03%

20Y return CAGR

15.89%

20Y total return

1,807.93%

3M price change

-19.22%

3M total return

-18.2%

3Y price change

-61.75%

3Y return CAGR

-25.3%

3Y total return

-58.32%

50-day SMA

EUR 36.46

50-day SMA vs 200-day SMA

50under200

52-week high

EUR 54.86

52-week high date

2026-01-23

52-week low

EUR 30.29

52-week low date

2026-03-27

5Y price change

-24.2%

5Y return CAGR

-3.22%

5Y total return

-15.1%

6M price change

-0.43%

6M total return

0.83%

All-time high

EUR 140.00

All-time high date

2024-06-26

All-time low

EUR 1.13

All-time low date

2002-07-26

Average true range (ATR)

EUR 0.87

Average volume

14.5K

Change from 52-week high

-36.38%

Change from 52-week low

15.22%

Change from all-time high

-75.07%

Change from all-time low

3,002.22%

Change from open

-0.57%

Day's gap

1.62%

Dollar volume

EUR 62,297

High price

EUR 35.10

Low price

EUR 34.51

Monthly RSI

35.6

Open price

EUR 35.10

Position in 52-week range

66.1%

Previous close

EUR 34.54

Price vs 150-day SMA

-8.15%

Price vs 20-day SMA

1.89%

Price vs 200-day SMA

-9.06%

Price vs 50-day SMA

-4.27%

Relative volume

0.12

RSI

48.69

Sharpe ratio

-0.32

Sharpe ratio (3Y)

-0.56

Sharpe ratio (5Y)

-0.03

Sortino ratio

-0.31

Sortino ratio (3Y)

-0.61

Sortino ratio (5Y)

0.1

Volume

1.8K

Weekly RSI

40.17

YTD price change

-20.76%

YTD total return

-16.96%

Metric

Value

Float

3.2B

Shares change (QoQ)

-0.29%

Shares change (YoY)

-0.14%

Shares held by insiders

0.02%

Shares held by institutions

27.53%

FRA/NOV (FRA/NOV)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/NOV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/NOV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/NOV

Frequently asked questions

FRA/NOV (FRA/NOV)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/NOV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/NOV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/NOV

Frequently asked questions